Rubicon Research IPO Proceeds Utilized as per Plan for Q3 FY26
Rubicon Research's Monitoring Agency Report for Q3 FY26 confirms IPO proceeds utilization aligns with objectives. ₹2,975 million utilized for debt prepayment, inorganic growth, and expenses. Unutilized ₹2,025 million deployed in FDs and accounts. No deviation from IPO objects noted.
This announcement is a standard regulatory filing detailing the utilization of IPO funds, which is a routine process. It does not introduce new material information that would significantly impact the company's stock or market perception.
The report is a routine monitoring agency submission confirming that IPO proceeds are being utilized as planned, with no deviations. This indicates a neutral financial and operational status.
Rubicon Research Limited (formerly Rubicon Research Private Limited) has submitted its Monitoring Agency Report for the quarter ended December 31, 2025. The report, issued by India Ratings and Research Private Limited, confirms that the utilization of proceeds from the company's Initial Public Offering (IPO) has been in line with the stated objects.
The IPO, which occurred between October 9, 2025, and October 13, 2025, raised a total of ₹13,775 million (approximately ₹1377.5 crore), comprising a fresh issue of ₹5,000 million (₹500 crore) and an offer for sale of ₹8,775 million (₹877.5 crore). The proceeds from the fresh issue were intended for specific purposes, including ₹3,100 million (₹310 crore) for prepayment of outstanding borrowings and ₹1,612.74 million (₹161.27 crore) for funding inorganic growth, acquisitions, and general corporate purposes. An additional ₹287.26 million (₹28.73 crore) was allocated for offer-related expenses.
As of December 31, 2025, a total of ₹2,975 million (₹297.5 crore) of the IPO proceeds had been utilized. Specifically, ₹2,521.38 million (₹252.14 crore) was used for debt prepayment, ₹350.63 million (₹35.06 crore) for inorganic growth and general corporate purposes, and ₹102.99 million (₹10.30 crore) for offer-related expenses. The unutilized amount stands at ₹2,025 million (₹202.5 crore), which was deployed in various fixed deposits and maintained in escrow and monitoring accounts.
The report also details the utilization of ₹260.90 million (₹26.09 crore) for general corporate purposes, including self-assessed tax payments, salary payments, and operational expenditures. The Monitoring Agency has confirmed no deviation from the objects as per the management representation and the statutory auditor's certificate dated February 2, 2026, issued by Deloitte Haskins & Sells LLP. The Audit Committee and the Board of Directors reviewed and took on record this report on February 3, 2026.
What to do with a filing like this
Rubicon Research Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rubicon Research Limited. Read the original for the full detail.